Come on people. If CF-33 is a duster, there is no OnCARlytics, yet they are recruiting … I’ll let you join the dots.
How about we give some credit to the poor souls who are on deaths door yet willing to take part in this experimental drug, they are the true champions.
Anyone whinging about the share price ought to consider that these drugs are life and death for some people, and sometimes assessing them takes more time.
Add to My Watchlist
What is My Watchlist?
